New Frontier Health (New Frontier Corp.) ^{Priced, NYSE: NFH.XX}

While we may pursue a business combination target in any business or industry, we intend to focus our search for a target with operations or prospects in the healthcare, technology or education sectors in China, which we refer to as the Chinese new economy sectors. We will not conduct our initial business combination with an early stage life sciences or biotechnology company, or with a company that principally owns real estate that is not incidental to its operating business. We believe that China is entering a new era of economic growth, particularly in the Chinese new economy sectors, which we expect will result in attractive initial business combination opportunities for us. We believe this growth will be driven by private sector expansion, technological innovation, increasing consumption by the middle class, structural economic and policy reforms and demographic changes in China. Our management team is led by our founders Antony Leung, our Chairman, and Carl Wu, our Chief Executive Officer, the co-founders of sponsor NFG, who have decades of experience investing in and building companies with operations in Greater China.